Safety and efficacy of BCG re-vaccination in relation to COVID-19 morbidity in healthcare workers: A double-blind, randomised, controlled, phase 3 trial

BACKGROUND: BCG vaccination prevents severe childhood tuberculosis (TB) and was introduced in South Africa in the 1950s. It is hypothesised that BCG trains the innate immune system by inducing epigenetic and functional reprogramming, thus providing non-specific protection from respiratory tract infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Upton, Caryn M., van Wijk, Rob C., Mockeliunas, Laurynas, Simonsson, Ulrika S.H., McHarry, Kirsten, van den Hoogen, Gerben, Muller, Chantal, von Delft, Arné, van der Westhuizen, Helene-Mari, van Crevel, Reinout, Walzl, Gerhard, Baptista, Pedro M., Peter, Jonathan, Diacon, Andreas H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098089/
https://www.ncbi.nlm.nih.gov/pubmed/35582122
http://dx.doi.org/10.1016/j.eclinm.2022.101414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098089/
https://www.ncbi.nlm.nih.gov/pubmed/35582122
http://dx.doi.org/10.1016/j.eclinm.2022.101414

Ejemplares similares